Hundreds of Studies Show Efficacy of One Particular Brain Fitness Program
January 21, 2025 08:00 ET
|
Posit Science
SAN FRANCISCO, Jan. 21, 2025 (GLOBE NEWSWIRE) -- New data from papers published in science and medical journals in 2024 shows tremendous growth in the evidence of efficacy of one particular brain...
NeuroAge Therapeutics: Revolutionary Brain Health Test Predicts Dementia Risk 30 Years in Advance
November 25, 2024 21:01 ET
|
NeuroAge Therapeutics
NeuroAge Therapeutics launches the NeuroAge Test, a cutting-edge tool predicting dementia risk 30 years early to optimize brain health
Internal Healthcare Group Launches as a Comprehensive Referral Platform for Senior Care Services Across the U.S. and Australia
November 08, 2024 12:29 ET
|
Internal Healthcare
TAMPA, Fla., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Internal Healthcare Group, a newly founded senior referral service, is excited to announce its virtual launch, introducing a unique approach to...
Bridging Health Equity Gaps: Creyos Launches an Even More Accessible Patient Experience
November 05, 2024 08:00 ET
|
Creyos
Toronto, Canada, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Creyos, a leader in cognitive and behavioral health assessment, has announced significant enhancements to its online platform to improve...
Psychiatry Collaboration and Licensing Deals Agreements Report and Directory 2024: Upfront, Milestone, Royalties - Company A-Z, Therapy Focus and Technology Type
September 30, 2024 05:20 ET
|
Research and Markets
Dublin, Sept. 30, 2024 (GLOBE NEWSWIRE) -- The "Psychiatry Collaboration and Licensing Deals 2019-2024" report has been added to ResearchAndMarkets.com's offering.Psychiatry Collaboration and...
Tiziana Life Sciences Announces $4 Million Grant Awarded by National Institutes of Health to Study Anti-CD3 in Alzheimer’s Disease
September 19, 2024 07:00 ET
|
Tiziana Life Sciences Ltd.
NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
VitalCaring’s AI-driven Cognitive Care Pilot Shows Promising Results
September 12, 2024 07:26 ET
|
Constant Therapy Health; VitalCaring
VitalCaring’s AI-driven cognitive care pilot shows statistically significant cognitive improvements. Provider to extend initiative across its network.
Author Sonya Jury Shares Life Lessons in Her New Book Mom Forgot My Birthday: A Daughter’s Journey Through Alzheimer’s
August 26, 2024 07:00 ET
|
Sonya Jury, Author
Sonya Jury shares her lessons as a caregiver in her book, "Mom Forgot My Birthday: A Daughter’s Journey Through Alzheimer’s."
Alzheimer's Disease Diagnostics & Therapeutics Market Driven by Use of Biomarkers and Advancing R&D Activities
August 06, 2024 09:00 ET
|
FN Media Group LLC
PALM BEACH, Fla., Aug. 06, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - According to a report from Mordor Intelligence, the Alzheimer's Disease Diagnostics And Therapeutics Market size...
Lucrative Incentive for Biotechs as Global Alzheimer's Disease Therapeutics Market Forecasted to Reach $30.8 Billion By 2033
August 06, 2024 08:30 ET
|
FN Media Group LLC
PALM BEACH, Fla., Aug. 06, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The growth of the Alzheimer's Disease Therapeutics Market is directly influenced by the increasing prevalence of...